For bacteria, microplastics are the perfect meetup spot—tiny, intimate surfaces where microbes can cling, huddle close and swap genes. And these crowded bacterial breeding grounds may pose a threat to human health. A growing body of new research shows that...

It was, says 48-year-old Andrea Dowden, 'one of the worst experiences of my life'. The raised, red scabs, which seemed to appear overnight, covered the mother-of-two's body.

Easy access to desperately needed drugs has made India the global accelerant of our antimicrobial resistance crisis

The first new treatments for gonorrhoea in decades could be a “huge turning point” in efforts to combat the rise of superbug strains of the bacteria, researchers have said. Gonorrhoea is on the rise around the world, with more than...

There are new signs that a dangerous fungus is once again on the move. Candida auris is a type of yeast that can cause life-threatening illness.

Scientists have found that a little-known bacterial antibiotic is capable of disarming fungi responsible for life-threatening infections. It's a welcome discovery in a world where drug-resistant fungi are becoming an increasingly serious global health concern. "Fungal infections kill an estimated two million people worldwide each year, yet treatment options remain limited," explains molecular biologist Ana Traven of Monash University in Australia, who led the research published in Current Biology. "Modern medicine, from surgery and cancer treatment to organ transplantation and intensive care, depends on our ability to prevent and treat these life-threatening infections." Traven and her colleagues have found an existing but little-known antibiotic that might be able to help. "There are no vaccines for fungal infections, and some of the antifungal medicines we do have can be highly toxic, highlighting the urgent need for new ways to prevent and treat these diseases," Traven says. Candida albicans is a typically benign yeast that lives on and inside our bodies, mostly unnoticed – until, on very rare occasions, it can become pathogenic. Infection usually only happens in people who are already really sick or immunocompromised, or who have risk factors such as major surgery or invasive medical devices. C. albicans can...

A drug-resistant type of bacteria that has adapted to health care settings evolved in the past several years to weaponize an antimicrobial genetic tool, eliminating its cousins and replacing them as the dominate strain. University of Pittsburgh School of Medicine...

Some 93% of people in lower income countries are struggling to access the appropriate drugs to treat antibiotic-resistant infections, research suggests.

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research team designed more than 36 million possible compounds and...

Years of progress against tuberculosis, the world’s most deadliest infectious disease are being derailed by the abrupt funding cuts by the United States to the sector, according to a survey of 180 affected organisations released late Wednesday. As many as...

Background Previously, drug-resistant tuberculosis (DR-TB) patients were treated with long, toxic, and relatively ineffective regimens. However, in recent years, there have been major improvements mad...

Our analysis reflects the complexity of drug resistance mutations in China and suggests that indel mutations, efflux pump genes, protein structure, and MICs should be fully considered in the WHO catalogue, especially in countries with a high tuberculosis burden.